The Safety and Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study

BACKGROUND: Neoadjuvant anti-programmed death receptor-1 (PD-1) blockade has been explored in the treatment of locally advanced esophageal squamous cell carcinoma (ESCC). We conducted this study to assess the efficacy and safety of neoadjuvant camrelizumab plus chemotherapy in locally advanced ESCC....

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Guo-Qiang, Li, Zu-Lei, Li, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251418/
https://www.ncbi.nlm.nih.gov/pubmed/35795828
http://dx.doi.org/10.2147/CMAR.S358620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251418/
https://www.ncbi.nlm.nih.gov/pubmed/35795828
http://dx.doi.org/10.2147/CMAR.S358620

Ejemplares similares